It All Starts With a Protein – Protein Sciences as a Key to Success in Drug Discovery

Biography 

Dr Errey has an MSc in Biotechnology from the University of Kent (1999) and a Ph.D. in carbohydrate biochemistry from the University of East Anglia (2003) under the supervision of Professor Rob Field. He then went on to spend three years as a postdoctoral fellow in the laboratory of Professor John Blanchard at Albert Einstein College of Medicine New York studying the enzymology of mycobacterial proteins. In 2006 he returned to the U.K. as a postdoctoral fellow in the laboratory of Professor Ben Davis at Oxford University, exploring new methods for the selective post-translational modification of proteins.

In 2008 he joined Heptares Therapeutics Ltd, a GPCR drug discovery company utilizing a novel structure-based drug discovery approach. During his time at Heptares he setup the protein biochemistry and biophysics platform helping to enable the structural determination of a number of therapeutically relevant GPCRs. In 2019 he left SoseiHeptares to Join Evotec as VP Head of Global Protein Production where he is heading Evotecs global protein biochemistry platform.